Rejection Issues Continue with Embryonic Stem Cells

by Jennifer Lahl, CBC President on August 28, 2008

There is good news and bad news with this story. The good news is this:

“The much-ballyhooed human embryonic stem cell apparently may share a problem with transplanted organs: a high probability of rejection.” So say the researchers at the Stanford University School of Medicine.

“The finding means that people who may one day be treated using pools of stem cells taken from many lines could reject them, making the therapy useless.

“[This result is] not a disappointment, it’s more of a reality check,” Wu says. “I think there’s some promise [to hESCs], but you don’t want to be foolish and say these cells are going to cure things in the next five years.””

The bad news of course is the reality that this will only encourage researchers to want to pursue “therapeutic cloning“. You know, the idea that we all will have our “own personal repair kit” on the Island for when we get sick and need a treatment.

Previous post:

Next post: